These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 23064471

  • 1. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
    Hou L, Xu B, Mohankumar KM, Goffin V, Perry JK, Lobie PE, Liu DX.
    Int J Oncol; 2012 Dec; 41(6):2285-95. PubMed ID: 23064471
    [Abstract] [Full Text] [Related]

  • 2. HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells.
    Mohankumar KM, Xu XQ, Zhu T, Kannan N, Miller LD, Liu ET, Gluckman PD, Sukumar S, Emerald BS, Lobie PE.
    Oncogene; 2007 Jun 07; 26(27):3998-4008. PubMed ID: 17213808
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional activation of signal transducer and activator of transcription (STAT) 3 and STAT5B partially mediate homeobox A1-stimulated oncogenic transformation of the immortalized human mammary epithelial cell.
    Mohankumar KM, Perry JK, Kannan N, Kohno K, Gluckman PD, Emerald BS, Lobie PE.
    Endocrinology; 2008 May 07; 149(5):2219-29. PubMed ID: 18276758
    [Abstract] [Full Text] [Related]

  • 4. CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways.
    Lim JH, Kim TY, Kim WH, Park JW.
    Breast Cancer Res Treat; 2011 Nov 07; 130(1):19-27. PubMed ID: 21128111
    [Abstract] [Full Text] [Related]

  • 5. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells.
    Gutzman JH, Miller KK, Schuler LA.
    J Steroid Biochem Mol Biol; 2004 Jan 07; 88(1):69-77. PubMed ID: 15026085
    [Abstract] [Full Text] [Related]

  • 6. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.
    Llovera M, Pichard C, Bernichtein S, Jeay S, Touraine P, Kelly PA, Goffin V.
    Oncogene; 2000 Sep 28; 19(41):4695-705. PubMed ID: 11032019
    [Abstract] [Full Text] [Related]

  • 7. Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity.
    Zhao D, Ma G, Zhang X, He Y, Li M, Han X, Fu L, Dong XY, Nagy T, Zhao Q, Fu L, Dong JT.
    J Biol Chem; 2016 Jun 10; 291(24):12809-12820. PubMed ID: 27129249
    [Abstract] [Full Text] [Related]

  • 8. Re-evaluation of the prolactin receptor expression in human breast cancer.
    Galsgaard ED, Rasmussen BB, Folkesson CG, Rasmussen LM, Berchtold MW, Christensen L, Panina S.
    J Endocrinol; 2009 Apr 10; 201(1):115-28. PubMed ID: 19153125
    [Abstract] [Full Text] [Related]

  • 9. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
    Kavarthapu R, Tsai Morris CH, Dufau ML.
    Oncotarget; 2014 Oct 15; 5(19):9079-91. PubMed ID: 25193864
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior.
    Tang JZ, Zuo ZH, Kong XJ, Steiner M, Yin Z, Perry JK, Zhu T, Liu DX, Lobie PE.
    Endocrinology; 2010 Jan 15; 151(1):43-55. PubMed ID: 19966185
    [Abstract] [Full Text] [Related]

  • 12. EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element.
    Manfroid I, Van de Weerdt C, Baudhuin A, Martial JA, Muller M.
    Mol Cell Endocrinol; 2005 Jan 14; 229(1-2):127-39. PubMed ID: 15607537
    [Abstract] [Full Text] [Related]

  • 13. Regulation of prolactin receptor expression by the tumour promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate in human breast cancer cells.
    Ormandy CJ, Lee CS, Kelly PA, Sutherland RL.
    J Cell Biochem; 1993 May 14; 52(1):47-56. PubMed ID: 8320275
    [Abstract] [Full Text] [Related]

  • 14. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.
    Langenheim JF, Tan D, Walker AM, Chen WY.
    Mol Endocrinol; 2006 Mar 14; 20(3):661-74. PubMed ID: 16269515
    [Abstract] [Full Text] [Related]

  • 15. Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland.
    Hovey RC, Trott JF, Ginsburg E, Goldhar A, Sasaki MM, Fountain SJ, Sundararajan K, Vonderhaar BK.
    Dev Dyn; 2001 Oct 14; 222(2):192-205. PubMed ID: 11668597
    [Abstract] [Full Text] [Related]

  • 16. Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells.
    Kavarthapu R, Dufau ML.
    Oncotarget; 2016 Oct 04; 7(40):65602-65613. PubMed ID: 27564112
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.
    Xu J, Zhang Y, Berry PA, Jiang J, Lobie PE, Langenheim JF, Chen WY, Frank SJ.
    Mol Endocrinol; 2011 Apr 04; 25(4):597-610. PubMed ID: 21310852
    [Abstract] [Full Text] [Related]

  • 18. Alpha2-adrenoceptor agonists trigger prolactin signaling in breast cancer cells.
    Castillo LF, Rivero EM, Goffin V, Lüthy IA.
    Cell Signal; 2017 Jun 04; 34():76-85. PubMed ID: 28302567
    [Abstract] [Full Text] [Related]

  • 19. HOXA1 is required for E-cadherin-dependent anchorage-independent survival of human mammary carcinoma cells.
    Zhang X, Emerald BS, Mukhina S, Mohankumar KM, Kraemer A, Yap AS, Gluckman PD, Lee KO, Lobie PE.
    J Biol Chem; 2006 Mar 10; 281(10):6471-81. PubMed ID: 16373333
    [Abstract] [Full Text] [Related]

  • 20. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
    Gallego MI, Binart N, Robinson GW, Okagaki R, Coschigano KT, Perry J, Kopchick JJ, Oka T, Kelly PA, Hennighausen L.
    Dev Biol; 2001 Jan 01; 229(1):163-75. PubMed ID: 11133161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.